| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,690 |
3,537 |
$424K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,499 |
5,328 |
$422K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,757 |
1,649 |
$269K |
| T1015 |
Clinic visit/encounter, all-inclusive |
2,684 |
794 |
$120K |
| 87631 |
|
632 |
621 |
$89K |
| 80053 |
Comprehensive metabolic panel |
5,036 |
4,504 |
$48K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
250 |
240 |
$44K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,009 |
982 |
$39K |
| 80050 |
General health panel |
779 |
760 |
$37K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,551 |
5,774 |
$33K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
376 |
371 |
$32K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
897 |
892 |
$27K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
771 |
765 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
857 |
790 |
$23K |
| X0620 |
|
100 |
89 |
$23K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
187 |
182 |
$19K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
232 |
230 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
371 |
358 |
$18K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
228 |
226 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,013 |
1,847 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
606 |
577 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
225 |
218 |
$16K |
| 76830 |
Ultrasound, transvaginal |
344 |
338 |
$16K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
192 |
178 |
$15K |
| 80061 |
Lipid panel |
1,087 |
1,069 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
805 |
693 |
$14K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
324 |
265 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
690 |
667 |
$13K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
59 |
59 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
531 |
526 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
531 |
526 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
259 |
253 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
327 |
266 |
$10K |
| 82607 |
|
742 |
725 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,077 |
965 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
46 |
44 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,098 |
1,025 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
594 |
483 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
1,082 |
994 |
$7K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
144 |
143 |
$7K |
| 81001 |
|
2,690 |
2,550 |
$7K |
| 76536 |
|
145 |
143 |
$7K |
| 0002A |
|
162 |
162 |
$7K |
| 83735 |
|
1,117 |
998 |
$7K |
| 84484 |
|
846 |
740 |
$7K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
40 |
40 |
$7K |
| 84439 |
|
765 |
743 |
$6K |
| 82728 |
|
526 |
498 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
480 |
456 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
172 |
165 |
$6K |
| 86618 |
|
224 |
221 |
$5K |
| 84702 |
|
289 |
234 |
$5K |
| 0001A |
|
164 |
164 |
$5K |
| 80076 |
|
553 |
534 |
$5K |
| 84703 |
|
446 |
428 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
739 |
719 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
226 |
224 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
294 |
243 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
79 |
74 |
$4K |
| 87040 |
|
238 |
210 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
18 |
14 |
$4K |
| 85730 |
|
701 |
642 |
$4K |
| 76641 |
|
69 |
68 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
156 |
153 |
$4K |
| 87081 |
|
705 |
698 |
$4K |
| 85027 |
|
563 |
501 |
$4K |
| 87186 |
|
393 |
370 |
$3K |
| 73564 |
|
154 |
135 |
$3K |
| 83540 |
|
419 |
402 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
346 |
179 |
$3K |
| 83605 |
|
465 |
403 |
$3K |
| 72110 |
|
149 |
143 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
155 |
152 |
$3K |
| 82570 |
|
434 |
418 |
$3K |
| 82043 |
|
382 |
373 |
$3K |
| 83690 |
|
639 |
582 |
$3K |
| 72141 |
|
13 |
12 |
$3K |
| 85610 |
|
859 |
745 |
$3K |
| 87077 |
|
341 |
322 |
$3K |
| 84550 |
|
383 |
354 |
$2K |
| 83880 |
|
85 |
76 |
$2K |
| 80320 |
|
179 |
168 |
$2K |
| 97161 |
|
41 |
39 |
$2K |
| 94729 |
|
71 |
71 |
$2K |
| 73610 |
|
99 |
92 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
45 |
43 |
$2K |
| 94726 |
|
70 |
70 |
$2K |
| 93971 |
|
25 |
24 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
194 |
189 |
$2K |
| 73030 |
|
102 |
97 |
$2K |
| 82784 |
|
53 |
51 |
$2K |
| 73630 |
|
136 |
132 |
$2K |
| 97162 |
|
24 |
24 |
$1K |
| 83550 |
|
292 |
281 |
$1K |
| 86850 |
|
180 |
172 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
109 |
100 |
$1K |
| 86038 |
|
84 |
80 |
$1K |
| 85652 |
|
427 |
399 |
$1K |
| 71250 |
|
25 |
25 |
$1K |
| 85379 |
|
106 |
103 |
$1K |
| 86140 |
|
387 |
356 |
$1K |
| 80081 |
|
12 |
12 |
$978.98 |
| 86787 |
|
50 |
49 |
$918.95 |
| 73130 |
|
76 |
74 |
$916.85 |
| 82565 |
|
166 |
161 |
$877.81 |
| 94060 |
|
99 |
99 |
$871.15 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$826.25 |
| 87797 |
|
38 |
38 |
$808.64 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
24 |
14 |
$765.31 |
| 83655 |
|
65 |
65 |
$716.55 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
104 |
102 |
$677.25 |
| 86592 |
|
179 |
175 |
$673.61 |
| 84153 |
|
27 |
27 |
$617.80 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
15 |
$614.88 |
| 73110 |
|
51 |
48 |
$569.92 |
| 86431 |
|
65 |
64 |
$486.29 |
| 83001 |
|
25 |
25 |
$421.75 |
| 93017 |
|
12 |
12 |
$375.42 |
| 72052 |
|
12 |
12 |
$357.50 |
| 86901 |
|
106 |
102 |
$355.50 |
| 86900 |
|
106 |
102 |
$350.88 |
| 84403 |
|
14 |
13 |
$324.00 |
| 81025 |
|
79 |
78 |
$303.49 |
| 84460 |
|
45 |
44 |
$299.52 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
34 |
28 |
$247.50 |
| 81003 |
|
80 |
80 |
$226.70 |
| 80329 |
|
28 |
27 |
$217.92 |
| 84450 |
|
28 |
28 |
$195.15 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
724 |
619 |
$171.07 |
| 82746 |
|
14 |
14 |
$142.80 |
| 96376 |
|
148 |
92 |
$128.88 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
240 |
177 |
$114.29 |
| 82248 |
|
19 |
15 |
$106.68 |
| 87070 |
|
15 |
14 |
$106.26 |
| J2704 |
Injection, propofol, 10 mg |
30 |
24 |
$96.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
98 |
85 |
$91.23 |
| 82550 |
|
12 |
12 |
$79.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
359 |
324 |
$47.37 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
21 |
17 |
$37.13 |
| 0353U |
|
14 |
13 |
$32.51 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
475 |
405 |
$29.63 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
198 |
188 |
$29.60 |
| 36415 |
Collection of venous blood by venipuncture |
719 |
532 |
$15.91 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
149 |
133 |
$13.56 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
33 |
29 |
$6.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
36 |
29 |
$6.02 |
| J2060 |
Injection, lorazepam, 2 mg |
30 |
27 |
$3.72 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
56 |
53 |
$1.82 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
14 |
12 |
$1.29 |
| A9270 |
Non-covered item or service |
38 |
24 |
$0.00 |
| 87581 |
|
21 |
19 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
169 |
161 |
$0.00 |